S7710
TRAPeze™ RT Telomerase Detection Kit
A highly sensitive in vitro assay for the fluorometric detection & real time quantification of telomerase activity in cells.
Synonym(s):
TRAP Assay
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12161503
eCl@ss:
32161000
NACRES:
NA.32
Recommended Products
Quality Level
manufacturer/tradename
Chemicon®
TRAPeze™
application(s)
genomic analysis
shipped in
dry ice
General description
Telomeres are specific structures found at the end of chromosomes in eukaryotes. In human chromosomes, the telomeres consist of thousands of copies of 6 base repeats (TTAGGG)(1-3). It has been suggested that telomeres protect chromosome ends since damaged chromosomes lacking telomeres undergo fusion, rearrangement and translocation (2). In somatic cells, telomere length is progressively shortened with each cell division both in vivo and in vitro (4-7) due to the inability of the DNA polymerase complex to synthesize the very 5′ end of the lagging strand (8,9).
Telomerase is a ribonucleoprotein that synthesizes and directs the telomeric repeats onto the 3′ end of existing telomeres using its RNA component as a template (10-14). Telomerase activity has been shown to be specifically expressed in immortal cells, cancer and germ cells (15,16) where it compensates for telomere shortening during DNA replication and thus stabilizes telomere length (7,17). These observations have led to a hypothesis that telomere length may function as a "mitotic clock" to sense the number of cell divisions and eventually signal replicative senescence or programmed cell death when a critical telomere length is achieved. Therefore, expression of telomerase activity in cancer cells may be a necessary and essential step for tumor development and progression (16,18-20). The causal relationship between expression of telomerase and telomere length stabilization and the extension of the life span of the human cell has recently been reported (21).
The development of a sensitive and efficient PCR-based telomerase activity detection method, TRAP (Telomeric Repeat Amplification Protocol) (15, 22), has made possible large scale surveys of telomerase activity in human cells and tissues (15, 23-29). To date, telomerase activity has been detected in over 85% of all tumors tested spanning more than 20 different types of cancers (30-31).
The TRAPeze™ RT Telomerase Detection Kit is a highly sensitive in vitro assay for the fluorometric detection and real time quantification of telomerase activity. It incorporates refinements to the original TRAP assay that were first introduced in the gel-based TRAPeze™ Telomerase Detection Kit (Cat. No. S7700) and adds the ability to quantitate telomerase activity using fluorescence energy transfer (ET) primers similar to the TRAPeze™ XL Telomerase Detection Kit (Cat. No. S7707). As in the original TRAPeze™ Kit, primer sequence modifications that reduce amplification artifacts and PCR controls for standard curve generation are included. In addition, both the TRAPeze™ RT and XL Kits use fluorescence energy transfer (ET) primers to generate fluorescently labeled TRAP products which permit nonisotopic, quantitative analysis of telomerase activity.
The unique design of these ET primers (Amplifluor® primers) allows detection and quantification of telomerase activity by directly measuring real time fluorescence emission in the reaction vessels. Since Amplifluor® primers will fluoresce only upon incorporation into the TRAP products, post-PCR sample manipulations such as electrophoretic gel or ELISA analyses are eliminated, thereby reducing the the risk of carry-over contamination. Quantitative analysis is not compromised when detection is performed in a high-throughput 96-well format unlike platforms utilizing a qualitative ELISA. Additionaly, an additional stand alone control is provided separately to assess PCR inhibitors that may be present in experimental samples. (Please see product insert for references).
Telomerase is a ribonucleoprotein that synthesizes and directs the telomeric repeats onto the 3′ end of existing telomeres using its RNA component as a template (10-14). Telomerase activity has been shown to be specifically expressed in immortal cells, cancer and germ cells (15,16) where it compensates for telomere shortening during DNA replication and thus stabilizes telomere length (7,17). These observations have led to a hypothesis that telomere length may function as a "mitotic clock" to sense the number of cell divisions and eventually signal replicative senescence or programmed cell death when a critical telomere length is achieved. Therefore, expression of telomerase activity in cancer cells may be a necessary and essential step for tumor development and progression (16,18-20). The causal relationship between expression of telomerase and telomere length stabilization and the extension of the life span of the human cell has recently been reported (21).
The development of a sensitive and efficient PCR-based telomerase activity detection method, TRAP (Telomeric Repeat Amplification Protocol) (15, 22), has made possible large scale surveys of telomerase activity in human cells and tissues (15, 23-29). To date, telomerase activity has been detected in over 85% of all tumors tested spanning more than 20 different types of cancers (30-31).
The TRAPeze™ RT Telomerase Detection Kit is a highly sensitive in vitro assay for the fluorometric detection and real time quantification of telomerase activity. It incorporates refinements to the original TRAP assay that were first introduced in the gel-based TRAPeze™ Telomerase Detection Kit (Cat. No. S7700) and adds the ability to quantitate telomerase activity using fluorescence energy transfer (ET) primers similar to the TRAPeze™ XL Telomerase Detection Kit (Cat. No. S7707). As in the original TRAPeze™ Kit, primer sequence modifications that reduce amplification artifacts and PCR controls for standard curve generation are included. In addition, both the TRAPeze™ RT and XL Kits use fluorescence energy transfer (ET) primers to generate fluorescently labeled TRAP products which permit nonisotopic, quantitative analysis of telomerase activity.
The unique design of these ET primers (Amplifluor® primers) allows detection and quantification of telomerase activity by directly measuring real time fluorescence emission in the reaction vessels. Since Amplifluor® primers will fluoresce only upon incorporation into the TRAP products, post-PCR sample manipulations such as electrophoretic gel or ELISA analyses are eliminated, thereby reducing the the risk of carry-over contamination. Quantitative analysis is not compromised when detection is performed in a high-throughput 96-well format unlike platforms utilizing a qualitative ELISA. Additionaly, an additional stand alone control is provided separately to assess PCR inhibitors that may be present in experimental samples. (Please see product insert for references).
The TRAPeze™ RT Telomerase Detection Kit is a highly sensitive in vitro assay for the fluorometric detection and real time quantification of telomerase activity. It incorporates refinements to the original TRAPeze™ assay and adds the ability to quantitate telomerase activity using fluorescence energy transfer (ET) primers.
Packaging
The kit provides enough reagents to perform 224 TRAPeze™ RT reactions.
Components
CHAPS Lysis Buffer (13.5mL)
5X TRAPeze™ RT Reaction Mix (1.12mL)
5X TRAPeze™ Control Reaction Mix (1.12mL)
PCR - Grade Water (8.2mL)
TSR8* (quantitation control template) (45 μL)
TSK* (pcr inhibition/normalization control) (45 μL)
Control Cell Pellet (Telomerase positive cells; 106 cells)
* Caution - refer to Sec. II. Kit Components, Precautions in product insert.
5X TRAPeze™ RT Reaction Mix (1.12mL)
5X TRAPeze™ Control Reaction Mix (1.12mL)
PCR - Grade Water (8.2mL)
TSR8* (quantitation control template) (45 μL)
TSK* (pcr inhibition/normalization control) (45 μL)
Control Cell Pellet (Telomerase positive cells; 106 cells)
* Caution - refer to Sec. II. Kit Components, Precautions in product insert.
Storage and Stability
1. CHAPS Lysis Buffer - 15°C to -25°C
2. 5X TRAPeze™ RT Reaction Mix -15°C to -25°C
3. 5X TRAPeze™ Control Reaction Mix 2°C to 8°C
4. PCR - Grade Water - 15°C to -25°C
5. TSR8 -15°C to -25°C
6. TSK -15°C to -25°C
7. Control Cell Pellet -75°C to -85°C
2. 5X TRAPeze™ RT Reaction Mix -15°C to -25°C
3. 5X TRAPeze™ Control Reaction Mix 2°C to 8°C
4. PCR - Grade Water - 15°C to -25°C
5. TSR8 -15°C to -25°C
6. TSK -15°C to -25°C
7. Control Cell Pellet -75°C to -85°C
Legal Information
ABI PRISM is a registered trademark of Applera Corporation or its subsidiaries in the US and/or certain other countries
Amplifluor is a registered trademark of Merck KGaA, Darmstadt, Germany
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Opticon is a trademark of Bio-Rad Laboratories, Inc.
TRAPEZE is a trademark of Merck KGaA, Darmstadt, Germany
iCycler is a registered trademark of Bio-Rad
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Chronic 3 - Met. Corr. 1
Storage Class Code
8B - Non-combustible corrosive hazardous materials
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Sadia Mohsin et al.
Circulation research, 113(10), 1169-1179 (2013-09-21)
Myocardial function is enhanced by adoptive transfer of human cardiac progenitor cells (hCPCs) into a pathologically challenged heart. However, advanced age, comorbidities, and myocardial injury in patients with heart failure constrain the proliferation, survival, and regenerative capacity of hCPCs. Rejuvenation
A Static Magnetic Field Inhibits the Migration and Telomerase Function of Mouse Breast Cancer Cells.
Zhu Fan et al.
BioMed research international, 2020, 7472618-7472618 (2020-05-29)
Static magnetic field (SMF) has a potential as a cancer therapeutic modality due to its specific inhibitory effects on the proliferation of multiple cancer cells. However, the underlying mechanism remains unclear, and just a few studies have examined the effects
Sylwia Kabacik et al.
Aging, 10(10), 2800-2815 (2018-10-18)
The paramount role of senescent cells in ageing has prompted suggestions that re-expression of telomerase may prevent ageing; a proposition that is predicated on the assumption that senescent cells are the sole cause of ageing. Recently, several DNA methylation-based age
Stanley T Parish et al.
Journal of immunology (Baltimore, Md. : 1950), 182(7), 4237-4243 (2009-03-21)
Expanded populations of CD8(+) T lymphocytes lacking CD28 expression are associated with a variety of deleterious clinical outcomes, including early mortality in the elderly, more rapid progression to AIDS, cardiovascular disease, and enhanced tumor cell growth. In cell culture, irreversible
Rong-Jane Chen et al.
Cell death & disease, 8(8), e2985-e2985 (2017-08-11)
Cellular senescence is characterized by permanent cell cycle arrest, triggered by a variety of stresses, such as telomerase inhibition, and it is recognized as a tumor-suppressor mechanism. In recent years, telomerase has become an important therapeutic target in several cancers;
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service